Cargando…

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma is a type of blood cancer caused by the uncontrolled growth of antibody producing B cells (known as plasma cells) that reside in the bone marrow. It is classed as a largely incurable cancer as whilst patients respond well to initial chemotherapy treatments, unfortuna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, Georgia, Chantry, Andrew, Lawson, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616105/ https://www.ncbi.nlm.nih.gov/pubmed/34830842 http://dx.doi.org/10.3390/cancers13225687

Ejemplares similares

Potential of oncolytic viruses in the treatment of multiple myeloma
por: Bartee, Eric
Publicado: (2018)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

New agents in the Treatment of Myeloma Bone Disease
por: Ring, Elizabeth S., et al.
Publicado: (2017)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
por: Meyers, Daniel E., et al.
Publicado: (2017)

Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo
por: Vitovski, Srdjan, et al.
Publicado: (2012)

Oncolytic Virotherapy for Multiple Myeloma: Past, Present, and Future
por: Thirukkumaran, Chandini M., et al.
Publicado: (2011)

HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
por: Tazzyman, Simon, et al.
Publicado: (2023)

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
por: Marchica, Valentina, et al.
Publicado: (2020)

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
por: Bartee, Eric, et al.
Publicado: (2016)

Oncolytic Viruses for Canine Cancer Treatment
por: Sánchez, Diana, et al.
Publicado: (2018)

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease
por: Lawson, Michelle A., et al.
Publicado: (2015)

Oncolytic viruses in melanoma
por: Robinson, Camille, et al.
Publicado: (2022)

Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta
por: Naik, Shruthi, et al.
Publicado: (2012)

Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
por: Packiriswamy, Nandakumar, et al.
Publicado: (2020)

Oncolytic Viruses in the Treatment of Bladder Cancer
por: Potts, Kyle G., et al.
Publicado: (2012)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
por: Kalafati, Eleni, et al.
Publicado: (2023)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021)

Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma
por: Villa, Nancy.Y., et al.
Publicado: (2020)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
por: Oh, Chang-Myung, et al.
Publicado: (2020)

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
por: Paton‐Hough, Julia, et al.
Publicado: (2018)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Designing and building oncolytic viruses
por: Maroun, Justin, et al.
Publicado: (2017)

Tumor Restrictions to Oncolytic Virus
por: Vähä-Koskela, Markus, et al.
Publicado: (2014)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
por: Kelly, Kevin R., et al.
Publicado: (2017)

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
por: Wenthe, Jessica, et al.
Publicado: (2020)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Pierce, Kyle M., et al.
Publicado: (2021)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
por: Loskog, Angelica
Publicado: (2015)

Prospects for combined use of oncolytic viruses and CAR T-cells
por: Ajina, Adam, et al.
Publicado: (2017)

The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma
por: Crawford, Lisa J., et al.
Publicado: (2020)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
por: Nguyen, Hong-My, et al.
Publicado: (2021)

Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors
por: de Sostoa, Jana, et al.
Publicado: (2020)

The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
por: Haller, Scott D., et al.
Publicado: (2020)

Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
por: Hu, Henglong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ko92b243tru13lo69enar4deep